共 29 条
[1]
Ramadan NM(2006)New and future migraine therapy Pharmacol Ther 112 199-212
[2]
Buchanan TM(1993)The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats Ann Neurol 33 48-56
[3]
Goadsby PJ(2005)Calcitonin gene related peptide does not excite or sensitize meningeal nociceptors: implications for the pathophysiology of migraine Ann Neurol 58 698-705
[4]
Edvinsson L(2004)Calcitonin gene related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine N Engl J Med 350 1104-1110
[5]
Levy D(2008)Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine Neurology 70 1304-1312
[6]
Burstein R(2008)Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial Lancet 372 2089-2090
[7]
Strassman AM(2009)Antimigraine drugs: new frontiers Neurol Sci 30 S49-S54
[8]
Olesen J(2007)Aerosol delivery of ergotamine tartrate via a breath-synchronized plume-control inhaler in humans Curr Med Res Opin 23 3177-3187
[9]
Diener HC(2008)Safety and pharmacokinetics of dihydroergotamine mesylate administered via a novel (TEMPO_) Inhaler Headache 48 355-367
[10]
Husstedt IW(2005)Botulinum toxin type A for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study Headache 45 315-324